Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
clinical trials
gilead sciences
2
×
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
alector
alkermes
allergan
avrobio
baricitinib
bcma
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
caribou biosciences
celgene
clinical data
congress
crispr
darzalex
depression
detroit blog main
detroit top stories
drugs
duchenne muscular dystrophy
eli lilly
fda
ge ventures
gene editing
gene therapy
genentech
What
known
2
×
new
approved
bio
biopharma
congress
congressional
crispr
data
disease
drug
executives
fatty
feud
group
horizon
intercept
isn’t
later
liver
marketed
medicine
month
nash
nonalcoholic
ny
pharma
roster
roundup
spectacles
splash
stay
steatohepatitis
testify
track
tuned
vs
you’re
Language
Current search:
known
×
photo
×
" new york blog main "
×
" gilead sciences "
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More